vs
Marygold Companies, Inc.（MGLD）与Profound Medical Corp.（PROF）财务数据对比。点击上方公司名可切换其他公司
Marygold Companies, Inc.的季度营收约是Profound Medical Corp.的1.3倍（$7.6M vs $6.0M），Marygold Companies, Inc.净利率更高（-7.5% vs -136.8%，领先129.2%）
Marygold Companies, Inc.是一家总部位于美国的多元化控股企业，核心业务覆盖金融服务、特种制造及消费品三大板块，主要面向北美市场开展运营，通过对旗下子公司的战略投资与运营优化实现长期价值增长。
康派集团医疗SE & Co. KGaA是一家总部位于德国科布伦茨的上市软件企业，专注于为医疗领域开发并提供相关软件产品，面向诊所、药房、医学实验室与医院推出支持诊疗及运营工作的云化数字应用软件。截至2022年，该公司全球员工规模超9200人，业务覆盖56个国家，拥有超过160万用户。
MGLD vs PROF — 直观对比
营收规模更大
MGLD
是对方的1.3倍
$6.0M
净利率更高
MGLD
高出129.2%
-136.8%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $7.6M | $6.0M |
| 净利润 | $-576.0K | $-8.2M |
| 毛利率 | 74.0% | 66.8% |
| 营业利润率 | -8.3% | -123.3% |
| 净利率 | -7.5% | -136.8% |
| 营收同比 | -4.5% | — |
| 净利润同比 | 67.0% | — |
| 每股收益（稀释后） | $-0.01 | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MGLDPROF
| Q4 25 | $7.6M | $6.0M | ||
| Q3 25 | $7.0M | $5.1M | ||
| Q2 25 | $7.2M | $2.0M | ||
| Q1 25 | $7.0M | $2.3M | ||
| Q4 24 | $8.0M | — | ||
| Q3 24 | $7.9M | — | ||
| Q2 24 | $8.3M | — | ||
| Q1 24 | $7.9M | — |
净利润MGLDPROF
| Q4 25 | $-576.0K | $-8.2M | ||
| Q3 25 | $-356.0K | $-8.0M | ||
| Q2 25 | $-1.5M | $-15.7M | ||
| Q1 25 | $-1.0M | $-10.7M | ||
| Q4 24 | $-1.7M | — | ||
| Q3 24 | $-1.6M | — | ||
| Q2 24 | $-1.9M | — | ||
| Q1 24 | $-529.0K | — |
毛利率MGLDPROF
| Q4 25 | 74.0% | 66.8% | ||
| Q3 25 | 77.0% | 77.7% | ||
| Q2 25 | 67.8% | 81.7% | ||
| Q1 25 | 75.0% | 79.2% | ||
| Q4 24 | 74.1% | — | ||
| Q3 24 | 73.1% | — | ||
| Q2 24 | 72.5% | — | ||
| Q1 24 | 70.5% | — |
营业利润率MGLDPROF
| Q4 25 | -8.3% | -123.3% | ||
| Q3 25 | -18.2% | -176.2% | ||
| Q2 25 | -16.5% | -696.9% | ||
| Q1 25 | -21.4% | -477.0% | ||
| Q4 24 | -22.8% | — | ||
| Q3 24 | -27.4% | — | ||
| Q2 24 | -33.3% | — | ||
| Q1 24 | -18.7% | — |
净利率MGLDPROF
| Q4 25 | -7.5% | -136.8% | ||
| Q3 25 | -5.1% | -157.7% | ||
| Q2 25 | -20.4% | -792.3% | ||
| Q1 25 | -14.4% | -458.1% | ||
| Q4 24 | -21.8% | — | ||
| Q3 24 | -20.1% | — | ||
| Q2 24 | -22.5% | — | ||
| Q1 24 | -6.7% | — |
每股收益（稀释后）MGLDPROF
| Q4 25 | $-0.01 | $0.27 | ||
| Q3 25 | $-0.01 | $0.26 | ||
| Q2 25 | $-0.04 | $0.52 | ||
| Q1 25 | $-0.02 | $0.36 | ||
| Q4 24 | $-0.04 | — | ||
| Q3 24 | $-0.04 | — | ||
| Q2 24 | $-0.05 | — | ||
| Q1 24 | $-0.01 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.6M | $59.7M |
| 总债务越低越好 | — | $4.5M |
| 股东权益账面价值 | $22.7M | $66.4M |
| 总资产 | $27.8M | $77.5M |
| 负债/权益比越低杠杆越低 | — | 0.07× |
8季度趋势，按日历期对齐
现金及短期投资MGLDPROF
| Q4 25 | $11.6M | $59.7M | ||
| Q3 25 | $12.5M | $24.8M | ||
| Q2 25 | $12.8M | $35.2M | ||
| Q1 25 | $15.6M | $46.4M | ||
| Q4 24 | $14.9M | — | ||
| Q3 24 | $17.5M | — | ||
| Q2 24 | $15.0M | — | ||
| Q1 24 | $16.1M | — |
总债务MGLDPROF
| Q4 25 | — | $4.5M | ||
| Q3 25 | — | $4.5M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | — | $4.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益MGLDPROF
| Q4 25 | $22.7M | $66.4M | ||
| Q3 25 | $22.9M | $32.1M | ||
| Q2 25 | $23.0M | $39.3M | ||
| Q1 25 | $24.3M | $50.8M | ||
| Q4 24 | $23.4M | — | ||
| Q3 24 | $25.5M | — | ||
| Q2 24 | $26.6M | — | ||
| Q1 24 | $28.4M | — |
总资产MGLDPROF
| Q4 25 | $27.8M | $77.5M | ||
| Q3 25 | $28.4M | $42.3M | ||
| Q2 25 | $30.4M | $49.7M | ||
| Q1 25 | $33.5M | $60.9M | ||
| Q4 24 | $33.0M | — | ||
| Q3 24 | $35.9M | — | ||
| Q2 24 | $32.9M | — | ||
| Q1 24 | $33.7M | — |
负债/权益比MGLDPROF
| Q4 25 | — | 0.07× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-908.0K | $-6.6M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流MGLDPROF
| Q4 25 | $-908.0K | $-6.6M | ||
| Q3 25 | $-533.0K | $-9.6M | ||
| Q2 25 | $-3.3M | $-13.7M | ||
| Q1 25 | $-1.2M | $-8.3M | ||
| Q4 24 | $-770.0K | — | ||
| Q3 24 | $-893.0K | — | ||
| Q2 24 | $-1.9M | — | ||
| Q1 24 | $-658.0K | — |
自由现金流MGLDPROF
| Q4 25 | — | — | ||
| Q3 25 | $-562.0K | — | ||
| Q2 25 | $-3.4M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-776.0K | — | ||
| Q3 24 | $-940.0K | — | ||
| Q2 24 | $-2.0M | — | ||
| Q1 24 | — | — |
自由现金流率MGLDPROF
| Q4 25 | — | — | ||
| Q3 25 | -8.1% | — | ||
| Q2 25 | -46.8% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -9.7% | — | ||
| Q3 24 | -11.9% | — | ||
| Q2 24 | -23.8% | — | ||
| Q1 24 | — | — |
资本支出强度MGLDPROF
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.6% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 0.0% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MGLD
| Fund Management Related Party | $4.6M | 60% |
| Food Products | $1.7M | 22% |
| Beauty Products | $1.2M | 15% |
| Other | $268.0K | 4% |
PROF
暂无分部数据
